Evidence map›Paper›PMID 10933072›Full record

ReviewNeoplasia (New York, N.Y.)

Imaging transgene expression with radionuclide imaging technologies.

S S Gambhir, H R Herschman, S R Cherry, J R Barrio, N Satyamurthy, T Toyokuni, M E Phelps, S M Larson, J Balatoni, R Finn and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Neoplasia (New York, N.Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
26.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 362 citations in OpenAlex.

  1. Imaging in gene therapy of patients with glioma.Journal of neuro-oncology · 2003
    Trial
  2. Article
  3. PET reporter systems for the brain.Trends in neurosciences · 2023
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Molecular Imaging with Reporter Genes: Has Its Promise Been Delivered?Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Review
  10. Article
  11. Review
  12. Noninvasive PET Imaging of T cells.Trends in cancer · 2018
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

S S GambhirDepartment of Molecular and Medical Pharmacology, UCLA School of Medicine, Los angeles, CA 90095-1770, USA. sgambhir@mednet.ucla.edu
H R Herschman
S R Cherry
J R Barrio
N Satyamurthy
T Toyokuni
M E Phelps
S M Larson
J Balatoni
R Finn
M Sadelain
J Tjuvajev
R Blasberg
Memorial Sloan Kettering Cancer Center · USUniversity of California, Los Angeles · USUCLA Health · US

Funding

Reporter Imaging of Protein-Protein InteractionsR01CA082214 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GAMBHIR, SANJIV S · 1999 to 2019
$5.9M
BRAIN TUMOR IMAGING WITH NONMETABOLIZED AMINO ACIDSR01CA060706 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BLASBERG, RONALD G · 1994 to 1996
–
IMAGING GENE TRANSFER AND EXPRESSIONR01CA069769 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BLASBERG, RONALD G · 1997 to 1999
–
NCI NIH HHS R01 CA082214NCI NIH HHS R01 CA60706NCI NIH HHS R01 CA69769NCI NIH HHS R01 CA82214-01
6 · The paper itself

Abstract

A variety of imaging technologies are being investigated as tools for studying gene expression in living subjects. Noninvasive, repetitive and quantitative imaging of gene expression will help both to facilitate human gene therapy trials and to allow for the study of animal models of molecular and cellular therapy. Radionuclide approaches using single photon emission computed tomography (SPECT) and positron emission tomography (PET) are the most mature of the current imaging technologies and offer many advantages for imaging gene expression compared to optical and magnetic resonance imaging (MRI)-based approaches. These advantages include relatively high sensitivity, full quantitative capability (for PET), and the ability to extend small animal assays directly into clinical human applications. We describe a PET scanner (microPET) designed specifically for studies of small animals. We review "marker/reporter gene" imaging approaches using the herpes simplex type 1 virus thymidine kinase (HSV1-tk) and the dopamine type 2 receptor (D2R) genes. We describe and contrast several radiolabeled probes that can be used with the HSV1-tk reporter gene both for SPECT and for PET imaging. We also describe the advantages/disadvantages of each of the assays developed and discuss future animal and human applications.

Indexed as

AnimalsGene ExpressionHerpesvirus 1, HumanHumansMiceModels, BiologicalRadionuclide ImagingReceptors, Dopamine D2Thymidine KinaseTomography, Emission-ComputedTransgenesReceptors, Dopamine D2Thymidine Kinase

Identifiers

PMID10933072
PMCPMC1550287
OpenAlexW2013472804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.